Compagnie Financiere Richemont SA (CFR)

Switzerland


	Symbol		Exchange		Currency
	CFR		Switzerland		CHF	Delayed
	CFRz		BATS Europe		CHF	Delayed
	CFRUY		OTC Markets		USD	Delayed
	0QMU		London		CHF	Real-time
	CFRJ		Johannesburg		ZAR	Delayed

Currency in CHF

Disclaimer

130.85

-0.05(-0.04%)

Closed04/10

Fair Value

Day's Range

130.60

132.00

52 wk Range

102.95

151.10

CFR Income Statement

Featured here, the Income Statement (earnings report) for Compagnie Financiere Richemont SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

14,238

13,144

16,748

19,953

20,616

Total Revenues Growth

+1.78%

-7.68%

+27.42%

+19.14%

+3.32%

Cost Of Revenues

5,632

5,286

5,572

6,237

6,580

Gross Profit

8,606

7,858

11,176

13,716

14,036

Gross Profit Growth

-0.37%

-8.69%

+42.22%

+22.73%

+2.33%

Gross Profit Margin %

60.44%

59.78%

66.73%

68.74%

68.08%

Other Operating Expenses, Total

7,043

6,372

7,392

8,629

9,172

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.21%	-9.53%	+16.01%	+16.73%	+6.29%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6,839	6,103	7,219	8,581	9,137
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	204	269	173	48	35

Operating Income

1,563

1,486

3,784

5,087

4,864

Operating Income Growth

-19.6%

-4.93%

+154.64%

+34.43%

-4.38%

EBIT Margin %

10.98%

11.31%

22.59%

25.49%

23.59%

Net Interest Expenses

-69

-132

-114

-84

-22

Net Interest Expenses Growth

-72.5%

-91.3%

+13.64%

+26.32%

+73.81%

Interest Expense, Total

-192

-215

-221

-303

-444

Interest And Investment Income

123

83

107

219

422

Other Non Operating Expenses, Total

-251

169

-696

-189

-117

EBT, Excl. Unusual Items

1,243

1,523

2,974

4,814

4,725

Gain (Loss) On Sale Of Assets

-

-

24

-

-

Other Unusual Items, Total

-44

-8

-55

-1

-48

EBT, Incl. Unusual Items

1,198

1,515

2,943

4,758

4,655

EBT, Incl. Unusual Items Growth

-62.18%

+26.46%

+94.26%

+61.67%

-2.16%

EBT, Incl. Unusual Items Margin

8.41

11.53

17.57

23.85

22.58

Income Tax Expense

267

226

494

847

837

Net Income to Company

931

1,289

2,079

301

2,355

Minority Interest

2

12

-5

12

7

Net Income

933

1,301

2,074

313

2,362

Net Income Growth

-66.49%

+39.44%

+59.42%

-84.91%

+654.63%

Net Income Margin %

6.55%

9.9%

12.38%

1.57%

11.46%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

933

1,301

2,444

3,923

3,825

Basic EPS - Continuing Operations

1.65

2.3

4.31

6.89

6.64

Basic EPS - Continuing Operations Growth

-66.53%

+39.39%

+87.36%

+59.87%

-3.75%

Diluted EPS - Continuing Operations

1.65

2.3

4.26

6.8

6.6

Diluted EPS - Continuing Operations Growth

-66.59%

+39.49%

+85.33%

+59.87%

-2.95%

Basic Weighted Average Shares Outstanding

565

565.2

566.7

569

576.4

Diluted Weighted Average Shares Outstanding

566.8

566.6

574.4

576.7

579.4

Dividend Per Share

0.94

1.81

2.2

2.52

2.83

Dividend Per Share Growth

-47.24%

+91.44%

+21.65%

+14.63%

+12.07%

EBITDA

2,269

2,170

4,487

5,734

5,485

EBITDA Growth

-12.93%

-4.36%

+106.77%

+27.79%

-4.34%

EBITDA Margin %